bpc 157 safe BPC-157: Experimental Peptide Creates Risk for Athletes FDA panel backs compounded BPC-157,

For a 5mg vial reconstituted with 2.5mL of bacteriostatic water, the resulting concentration is 2mg/mL

(PubMed) Essen A, Santaolalla A, Garmo H, et al

most findings are preclinical

Neither were published and Pliva was so excited about the results it abandoned the drug entirely One Phase I safety and pharmacokinetics trial of oral BPC-157, registered in 2015, that has no public results and appears to have been withdrawn or abandoned Three small and nonrandomized uncontrolled pilot studies from a single for-profit clinic in Florida, which included a 16-patient knee-pain chart review, a 12-woman interstitial cystitis study, and a small intravenous safety study One legitimate entry: a registered Phase 2 trial of BPC-157 for acute hamstring strain

Advanced protocol Experienced researchers sometimes use higher doses, though diminishing returns and increased side effect risk apply